Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.
D Curiel, … , L Stier, R G Crystal
D Curiel, … , L Stier, R G Crystal
Published April 1, 1989
Citation Information: J Clin Invest. 1989;83(4):1144-1152. https://doi.org/10.1172/JCI113994.
View: Text | PDF | Correction
Research Article

Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin.

  • Text
  • PDF
Abstract

alpha 1-Antitrypsin (alpha 1AT) deficiency is a hereditary disorder associated with reduced serum alpha 1AT levels and the development of pulmonary emphysema. An alpha 1AT gene is defined as "Null" when no alpha 1AT in serum is attributed to that alpha 1AT gene. Although all alpha 1AT Null genes have identical phenotypic consequences (i.e. no detectable alpha 1AT in the serum), different genotypic mechanisms can cause the Null state. This study defines the molecular basis for the alpha 1AT gene Nullmattawa, identified and cloned from genomic DNA of an individual with the Null-Null phenotype and emphysema resulting from the heterozygous inheritance of the Nullmattawa and Nullbellingham genes. Sequencing of exons Ic-V and all exon-intron junctions of the Nullmattawa gene demonstrated it was identical to the common normal M1(Val213) alpha 1AT gene except for the insertion of a single nucleotide within the coding region of exon V, causing a 3' frameshift with generation of a premature stop signal. Family analysis using oligonucleotide probes specific for the Nullmattawa sequence demonstrated the gene was inherited in an autosomal fashion. Examination of blood monocytes demonstrated that a normal-sized, 1.8-kb alpha 1AT mRNA transcript is associated with the Nullmattawa gene and in vitro translation of mRNA with the Nullmattawa mutation showed it translated at a normal rate but produced a truncated alpha 1AT protein. Additionally, retroviral transfer of the alpha 1AT Nullmattawa cDNA to murine fibroblasts demonstrated no detectable intracellular or secreted alpha 1AT, despite the presence of alpha 1AT Nullmattawa mRNA transcripts. These findings are consistent with the concept that the molecular pathophysiology of Nullmattawa is likely manifested at a posttranslational level. The identification of the Nullmattawa gene supports the concept that Null alpha 1AT alleles represent a heterogenous group in which very different mechanisms cause the identical phenotypic state.

Authors

D Curiel, M Brantly, E Curiel, L Stier, R G Crystal

×

Total citations by year

Year: 2022 2021 2020 2017 2016 2015 2014 2013 2012 2011 2007 2002 2001 2000 1999 1998 1996 1994 1992 1991 1990 1989 1962 Total
Citations: 1 3 1 1 2 2 3 2 2 4 2 1 1 1 1 4 1 4 4 3 7 4 1 55
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (55)

Title and authors Publication Year
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver disease
Nan He, Xiaoming Liu, Amber R Vegter, T. Idil Evans, Jaimie S Gray, Junfeng Guo, Shashanna R Moll, Lydia J Guo, Meihui Luo, Ningxia Ma, Xingshen Sun, Bo Liang, Ziying Yan, Zehua Feng, Lisi Qi, Arnav S. Joshi, Weam Shahin, Yaling Yi, Katherine N Gibson-Corley, Eric A Hoffman, Kai Wang, Christian Mueller, John F Engelhardt, Bradley H Rosen
JCI Insight 2022
Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum
S Seixas, PI Marques
The Application of Clinical Genetics 2021
Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency
KE Foil
Therapeutic Advances in Chronic Disease 2021
The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém)
J Bellemare, N Gaudreault, K Valette, I Belmonte, A Nuñez, M Miravitlles, F Maltais, Y Bossé
Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 2021
Identification of Variants in Alpha-1-Antitrypsin by High Resolution Melting
G Bidla, DS Rosenblatt, BM Gilfix
2020
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions
YM Hazari, A Bashir, M Habib, S Bashir, H Habib, MA Qasim, NN Shah, E Haq, J Teckmane, KM Fazili
Mutation Research/Reviews in Mutation Research 2017
Novel variants of SERPIN1A gene: Interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease
A Bashir, NN Shah, YM Hazari, M Habib, S Bashir, N Hilal, M Banday, S Asrafuzzaman, KM Fazili
Respiratory Medicine 2016
Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal
D Silva, MJ Oliveira, M Guimarães, R Lima, S Gomes, S Seixas
Respiratory Medicine 2016
Animal Models of Chronic Obstructive Pulmonary Disease
S Pérez-Rial, Á Girón-Martínez, G Peces-Barba
Archivos de Bronconeumología (English Edition) 2015
Can we change a genetically determined future?
LR Fernandes, LV Rodrigues, F Costa, Y Martins
BMJ case reports 2015
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid
B Lara, MT Martínez, I Blanco, C Hernández-Moro, EA Velasco, I Ferrarotti, F Rodriguez-Frias, L Perez, I Vazquez, J Alonso, M Posada, B Martínez-Delgado
Respiratory Research 2014
Identification and characterisation of eight novel SERPINA1 Null mutations
I Ferrarotti, TP Carroll, S Ottaviani, AM Fra, G O’Brien, K Molloy, L Corda, D Medicina, DR Curran, NG McElvaney, M Luisetti
Orphanet Journal of Rare Diseases 2014
Modelos animales de enfermedad pulmonar obstructiva crónica
S Pérez-Rial, Á Girón-Martínez, G Peces-Barba
Archivos de Bronconeumología 2014
Déficit de alfa-1-antitripsina asociado a la variante Matawa
B Lara, B Martínez-Delgado, ML Torres, S Marín-Arguedas, A Bustamante, M Miravitlles
Archivos de Bronconeumología 2013
Alpha-1-Antitrypsin Deficiency Associated With the Mattawa Variant
B Lara, B Martínez-Delgado, ML Torres, S Marín-Arguedas, A Bustamante, M Miravitlles
Archivos de Bronconeumología (English Edition) 2013
Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression
RA Philibert, RA Sears, LS Powers, E Nash, T Bair, AK Gerke, I Hassan, CP Thomas, TJ Gross, MM Monick
Journal of leukocyte biology 2012
Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression
RA Philibert, RA Sears, LS Powers, E Nash, T Bair, AK Gerke, I Hassan, CP Thomas, TJ Gross, MM Monick
Journal of leukocyte biology 2012
Diagnóstico del déficit de alfa 1-antitripsina: limitaciones de las pruebas de laboratorio de diagnóstico rápido
F Rodríguez-Frías, B Vila-Auli, M Homs-Riba, R Vidal-Pla, JL Calpe-Calpe, R Jardi-Margalef
Archivos de Bronconeumología 2011
Severe α-1 antitrypsin deficiency caused by Q0Ourém allele: clinical features, haplotype characterization and history
LV Rodrigues, F Costa, P Marques, C Mendonça, J Rocha, S Seixas
Clinical Genetics 2011
Diagnosis of Alpha-1 Antitrypsin Deficiency: Limitations of Rapid Diagnostic Laboratory Tests
F Rodríguez-Frías, B Vila-Auli, M Homs-Riba, R Vidal-Pla, JL Calpe-Calpe, R Jardi-Margalef
Archivos de Bronconeumología (English Edition) 2011
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis
JA Dickens, DA Lomas
Drug design, development and therapy 2011
Alpha One Antitrypsin Deficiency: From Gene to Treatment
AM Wood, RA Stockley
Respiration 2007
A Retrospective Study and Gene Analysis of Canine Sterile Panniculitis
C YAMAGISHI, Y MOMOI, T KOBAYASHI, K IDE, K OHNO, H TSUJIMOTO, T IWASAKI
Journal of Veterinary Medical Science 2007
α1-Antitrypsin null alleles: evidence for the recurrence of the L353fsX376 mutation and a novel G→A transition in position +1 of intron IC affecting normal mRNA splicing
S Seixas, C Mendonça, F Costa, J Rocha
Clinical Genetics 2002
Diagnosis of alpha-1-antitrypsin deficiency by DNA analysis of children with liver disease
AM de TOMMASO, CL ROSSI, CA ESCANHOELA, HG SERRA, CS BERTUZZO, G HESSEL
Arquivos de Gastroenterologia 2001
Molecular mechanisms of alpha1-antitrypsin null alleles
J Lee, M Brantly
Respiratory Medicine 2000
Molecular Biology of the Lung
RA Stockley
1999
α1-Antitrypsin Nonsense Mutation Associated with a Retained Truncated Protein and Reduced mRNA
JH Lee, N Novoradovskaya, B Rundquist, J Redwine, C Saltini, M Brantly
Molecular Genetics and Metabolism 1998
An SP-B Gene Mutation Responsible for SP-B Deficiency in Fatal Congenital Alveolar Proteinosis: Evidence for a Mutation Hotspot in Exon 4
Z Lin, DE deMello, M Wallot, J Floros
Molecular Genetics and Metabolism 1998
4 α1-Antitrypsin deficiency
S Eriksson, AN Elzouki
Bailliere's Clinical Gastroenterology 1998
Pulmonary Cell Biology
RJ Mason, RG Crystal
American journal of respiratory and critical care medicine 1998
The Defective Secretion of a Naturally Occurring alpha-1-Antichymotrypsin Variant with a Frameshift Mutation
M Tsuda, Y Sei, T Ohkubo, M Yamamura, H Kamiguchi, A Akatsuka, T Tsuda, H Tachikawa, M Yamamoto, Y Shinohara
European Journal of Biochemistry 1996
Pathogenesis of liver disease in alpha1-antitrypsin deficiency
A Nemeth
Acta Paediatrica 1994
Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma
HC Hsu, AM Huang, PL Lai, WM Chien, SY Peng, SW Lin
Hepatology 1994
Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema
L Cook, ED Janus, SB néeWatts, E Tai, J Burdon
Australian and New Zealand Journal of Medicine 1994
Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele
JP Faber, W Poller, S Weidinger, M Kirchgesser, R Schwaab, F Bidlingmaier, K Olek
The American Journal of Human Genetics 1994
Only three mutations account for almost all defective alleles causing adenine phosphoribosyltransferase deficiency in Japanese patients
N Kamatani, M Hakoda, S Otsuka, H Yoshikawa, S Kashiwazaki
Journal of Clinical Investigation 1992
Genetic variants of alpha-1-antitrypsin (AAT)
G Fabbretti, C Sergl, G Consales, G Faa, M Brisigotti, G Romeo, F Callea
Liver 1992
Biochemistry of Pulmonary Emphysema
C Grassi, J Travis, L Casali, M Luisetti
1992
Secretion of alpha-1-proteinase inhibitor requires an almost full length molecule
RM Brodbeck, JL Brown
The Journal of biological chemistry 1992
The cellular basis for liver injury in α1-antitrypsin deficiency
DH Perlmutter
Hepatology 1991
Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI
S Gandrille, D Vidaud, J Emmerich, E Clauser, P Sié, JN Fiessinger, M Alhenc-Gelas, P Priollett, M Aiach
British Journal of Haematology 1991
DNA polymorphisms associated with a new ?1-antitrypsin PI Q0 variant (PI Q0riedenburg)
W Poller, JP Faber, S Weidinger, K Olek
Human Genetics 1991
Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer
T Takahashi, D D'Amico, I Chiba, DL Buchhagen, JD Minna
Journal of Clinical Investigation 1990
A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure
GC Frazier, MA Siewertsen, MH Hofker, MG Brubacher, DW Cox
Journal of Clinical Investigation 1990
Alpha 1-antitrypsin Null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons
H Takahashi, RG Crystal
The American Journal of Human Genetics 1990
Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele
DT Curiel, C Vogelmeier, RC Hubbard, LE Stier, RG Crystal
Molecular and cellular biology 1990
Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease
N Kalsheker, K Morgan
Thorax 1990
Highly variable clinical course in severeα 1-antitrypsin deficiency — Use of polymerase chain reaction for the detection of rare deficiency alleles
W Poller, , K Olek
Klinische Wochenschrift 1990
Molecular characterisation of two alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) NullNewport (Gly115?Ser) and (Pi) Z Wrexham (Ser?19?Leu)
A Graham, NA Kalsheker, FJ Bamforth, CR Newton, AF Markham
Human Genetics 1990
Alpha-1-antitrypsin Deficiency: Accumulation or Degradation of Mutant Variants within the Hepatic Endoplasmic Reticulum
RN Sifers, MJ Finegold, SL Woo
American journal of respiratory cell and molecular biology 1989
Deletion/frameshift mutation in the ?1 null allele, PI*QObolton
GC Fraizer, M Siewertsen, TR Harrold, DW Cox
Human Genetics 1989
Molecular Basis of the Liver and Lung Disease Associated with the α1-Antitrypsin Deficiency Allele Mmalton
DT Curiel, MD Holmes, H Okayama, ML Brantly, C Vogelmeier, WD Travis, LE Stier, WH Perks, RG Crystal
The Journal of biological chemistry 1989
Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256?Val); Pi Mmalton (Phe51? deletion) and Pi I (Arg39?Cys)
A Graham, NA Kalsheker, CR Newton, FJ Bamforth, SJ Powell, AF Markham
Human Genetics 1989
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel
1962

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts